| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6414cf0912e2737a41f574e3435772e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
| filingDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_516d38eb10ffe7947348659d5a3f7c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406a0e5b9d07b89905096430b280bb3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01979327a8c6fdbfad79f7c5b761059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511c37e834986ff4418979161f68f31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba4cdc15ef117b5ad7e751328cb1ee6 |
| publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201902514-A |
| titleOfInvention |
Use of PD-1 antibody in combination with VEGF ligand or VEGF receptor inhibitor for the preparation of a medicament for treating tumor |
| abstract |
The invention relates to the use of a PD-1 antibody combined with a VEGF ligand or a VEGF receptor inhibitor in the preparation of a medicament for treating tumors. The combined use of the PD-1 antibody and the VEGF ligand or VEGF receptor inhibitor in the present invention can not only play a synergistic use and enhance the anti-tumor effect, but also reduce or eliminate the capillary hemangioma caused by the anti-PD-1 antibody. reaction. |
| priorityDate |
2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |